• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

KSF Appointed Lead Counsel In Health Insurance Innovations Securities Litigation

Home»News»KSF Appointed Lead Counsel In Health Insurance Innovations Securities Litigation

On February 6, 2018, Hon. Elizabeth A. Kovachevich, the United States District Judge for the Middle District of Florida, ordered KSF’s appointment as lead counsel for the class in Kavra v. Health Insurance Innovations, Inc. et al., Case No. 8:17-cv-02186-EAK-MAP (M.D. Fla). Gunster, Yoakley & Stewat, P.A. was approved as Liaison Counsel. Lead Plaintiff alleges that, throughout the Class Period (March 4, 2016 through September 11, 2017, inclusive), Defendants made misleading statements and failed to disclose material information regarding the status-and importance- of their license to operate as a third-party administrator in their home state of Florida. The matter further alleges that when the truth was finally brought to light by a stock news website on September 11, 2017, HIIQ’s stock price fell from $29.90 to $23.35 for a decline of 22%.

Filed Under: News

Previous Post: « $17.5 Million Proposed Settlement in American Capital Ltd. to be Presented to Court
Next Post: Lead Plaintiffs Defeat Motion To Dismiss in Pearlstein v. Blackberry Ltd. »

Primary Sidebar

Current Cases

Cabot Oil & Gas Corporation (NYSE: COG)

Amyris, Inc. (NasdaqGS: AMRS)

Obalon Therapeutics, Inc. (NasdaqGS: OBLN)

Coherent, Inc. (NasdaqGS: COHR)

Penumbra, Inc. (NYSE: PEN)

Anchiano Therapeutics Ltd. (NasdaqGS: ANCN)

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2021 Copyright. All rights reserved Kahn Swick & Foti LLC · New Orleans · New York — Kahn Swick & Foti LLP · San Francisco

We recently updated our Privacy Policy. We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.OkPrivacy policy